The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Mechanisms of Antibiotic Resistance in Staphylococcus Aureus
Abstract
Staphylococcus aureus can exemplify better than any other human pathogen the adaptive evolution of bacteria in the antibiotic era, as it has demonstrated a unique ability to quickly respond to each new antibiotic with the development of a resistance mechanism, starting with penicillin and methicillin, until the most recent, linezolid and daptomycin. Resistance mechanisms include enzymatic inactivation of the antibiotic (penicillinase and aminoglycoside-modification enzymes), alteration of the target with decreased affinity for the antibiotic (notable examples being penicillin-binding protein 2a of methicillin-resistant S. aureus and D-Ala-D-Lac of peptidoglycan precursors of vancomycin-resistant strains), trapping of the antibiotic (for vancomycin and possibly daptomycin) and efflux pumps (fluoroquinolones and tetracycline). Complex genetic arrays (staphylococcal chromosomal cassette mec elements or the vanA operon) have been acquired by S. aureus through horizontal gene transfer, while resistance to other antibiotics, including some of the most recent ones (e.g., fluoroquinolones, linezolid and daptomycin) have developed through spontaneous mutations and positive selection. Detection of the resistance mechanisms and their genetic basis is an important support to antibiotic susceptibility surveillance in S. aureus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibacterial resistance worldwide: causes, challenges and responses
Levy, S. B., & Marshall, B. (2004) · Nature Medicine · doi:10.1038/nm1145 · Cited by 4,052
Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department
Moran, G. J., Krishnadasan, A., Gorwitz, R. J., Fosheim, G. E., McDougal, L. K., Carey, R. B., & Talan, D. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055356 · Cited by 2,285
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
Hiramatsu, K. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.135 · Cited by 1,984
Vandenesch, F., Naimi, T., Enright, M. C., Lina, G., Nimmo, G. R., Heffernan, H., Liassine, N., Bes, M., Greenland, T., Reverdy, M.-E., et al. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0908.030089 · Cited by 1,727
"Celbenin" - resistant Staphylococci
Jevons, M. P. (1961) · BMJ · doi:10.1136/bmj.1.5219.124-a · Cited by 1,680
Diep, B. A., Gill, S. R., Chang, R. F., Phan, T. H., Chen, J. H., Davidson, M. G., Lin, F., Lin, J., Carleton, H. A., Mongodin, E. F., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68231-7 · Cited by 1,633
Sampling the Antibiotic Resistome
D'Costa, V. M., McGrann, K. M., Hughes, D. W., & Wright, G. D. (2006) · Science · doi:10.1126/science.1120800 · Cited by 1,594
Antimicrobial resistance: the example of Staphylococcus aureus
Lowy, F. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18535 · Cited by 1,445
Hiramatsu, K., Aritaka, N., Hanaki, H., Kawasaki, S., Hosoda, Y., Hori, S., Fukuchi, Y., & Kobayashi, I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07324-8 · Cited by 1,333
Leclercq, R. (2002) · Clinical Infectious Diseases · doi:10.1086/324626 · Cited by 1,102
Katayama, Y., Ito, T., & Hiramatsu, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1549-1555.2000 · Cited by 1,038
Linezolid resistance in a clinical isolate of Staphylococcus aureus
Tsiodras, S., Gold, H. S., Sakoulas, G., Eliopoulos, G. M., Wennersten, C., Venkataraman, L., Moellering, R. C., & Ferraro, M. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05410-1 · Cited by 1,033
Vancomycin Resistance in Gram-Positive Cocci
Courvalin, P. (2006) · Clinical Infectious Diseases · doi:10.1086/491711 · Cited by 1,028
Genetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureus
Weigel, L. M., Clewell, D. B., Gill, S. R., Clark, N. C., McDougal, L. K., Flannagan, S. E., Kolonay, J. F., Shetty, J., Killgore, G. E., & Tenover, F. C. (2003) · Science · doi:10.1126/science.1090956 · Cited by 889
Platensimycin is a selective FabF inhibitor with potent antibiotic properties
Wang, J., Soisson, S. M., Young, K., Shoop, W., Kodali, S., Galgoci, A., Painter, R., Parthasarathy, G., Tang, Y. S., Cummings, R., et al. (2006) · Nature · doi:10.1038/nature04784 · Cited by 812
Staphylococcus aureus Panton-Valentine Leukocidin Causes Necrotizing Pneumonia
Labandeira-Rey, M., Couzon, F., Boisset, S., Brown, E. L., Bes, M., Benito, Y., Barbu, E. M., Vazquez, V., Höök, M., Etienne, J., et al. (2007) · Science · doi:10.1126/science.1137165 · Cited by 709
Long, K. S., Poehlsgaard, J., Kehrenberg, C., Schwarz, S., & Vester, B. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00131-06 · Cited by 708
Seybold, U., Kourbatova, E. V., Johnson, J. G., Halvosa, S. J., Wang, Y. F., King, M. D., Ray, S. M., & Blumberg, H. M. (2006) · Clinical Infectious Diseases · doi:10.1086/499815 · Cited by 695
Antimicrobial resistance of Staphylococcus aureus: genetic basis
Lyon, B. R., & Skurray, R. A. (1987) · Microbiological Reviews · doi:10.1128/mmbr.51.1.88-134.1987 · Cited by 686
Ito, T., Ma, X. X., Takeuchi, F., Okuma, K., Yuzawa, H., & Hiramatsu, K. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2637-2651.2004 · Cited by 675
Methicillin-Resistant Staphylococcus aureus in U.S. Hospitals, 1975–1991
Panlilio, A. L., Culver, D. H., Gaynes, R. P., Banerjee, S., Henderson, T. S., Tolson, J. S., Martone, W. J., & System, N. N. I. S. (1992) · Infection Control & Hospital Epidemiology · doi:10.1086/646432 · Cited by 657
Mulligan, M. E., Murray-Leisure, K. A., Ribner, B. S., Standiford, H. C., John, J. F., Korvick, J. A., Kauffman, C. A., & Yu, V. L. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90063-u · Cited by 641
Ma, X. X., Ito, T., Tiensasitorn, C., Jamklang, M., Chongtrakool, P., Boyle-Vavra, S., Daum, R. S., & Hiramatsu, K. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.4.1147-1152.2002 · Cited by 587
Oliveira, D. C., Tomasz, A., & de Lencastre, H. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00227-x · Cited by 494
Howden, B. P., Ward, P. B., Charles, P. G. P., Korman, T. M., Fuller, A., Cros, P. D., Grabsch, E. A., Roberts, S. A., Robson, J., Read, K., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/381202 · Cited by 484
Use of a Staphylococcus aureus Conjugate Vaccine in Patients Receiving Hemodialysis
Shinefield, H., Black, S., Fattom, A., Horwith, G., Rasgon, S., Ordonez, J., Yeoh, H., Law, D., Robbins, J. B., Schneerson, R., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011297 · Cited by 474
Genetic Changes That Correlate with Reduced Susceptibility to Daptomycin in Staphylococcus aureus
Friedman, L., Alder, J. D., & Silverman, J. A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00039-06 · Cited by 454
Cui, L., Tominaga, E., Neoh, H.-M., & Hiramatsu, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.1079-1082.2006 · Cited by 427
Glycopeptide resistance in enterococci
ARTHUR, M., REYNOLDS, P., & COURVALIN, P. (1996) · Trends in Microbiology · doi:10.1016/0966-842x(96)10063-9 · Cited by 414
Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus
Kaatz, G. W., Seo, S. M., & Ruble, C. A. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.1086 · Cited by 413
Increasing Resistance to Vancomycin and Other Glycopeptides in Staphylococcus aureus
Tenover, F. C., Biddle, J. W., & Lancaster, M. V. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010237 · Cited by 391
Moet, G. J., Jones, R. N., Biedenbach, D. J., Stilwell, M. G., & Fritsche, T. R. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.05.009 · Cited by 386
Pinho, M. G., de Lencastre, H., & Tomasz, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191260798 · Cited by 384
Chongtrakool, P., Ito, T., Ma, X. X., Kondo, Y., Trakulsomboon, S., Tiensasitorn, C., Jamklang, M., Chavalit, T., Song, J.-H., & Hiramatsu, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.1001-1012.2006 · Cited by 378
Vancomycin-Resistant Staphylococcus aureus Isolate from a Patient in Pennsylvania
Tenover, F. C., Weigel, L. M., Appelbaum, P. C., McDougal, L. K., Chaitram, J., McAllister, S., Clark, N., Killgore, G., O'Hara, C. M., Jevitt, L., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.275-280.2004 · Cited by 370
Siberry, G. K., Tekle, T., Carroll, K., & Dick, J. (2003) · Clinical Infectious Diseases · doi:10.1086/377501 · Cited by 343
Maree, C. L., Daum, R. S., Boyle-Vavra, S., Matayoshi, K., & Miller, L. G. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1302.060781 · Cited by 333
Liu, C., & Chambers, H. F. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3040-3045.2003 · Cited by 321
Fluoroquinolone resistance among Gram-positive cocci
Hooper, D. C. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00369-9 · Cited by 320
Blumberg, H. M., Rimland, D., Carroll, D. J., Terry, & Wachsmuth, I. K. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/163.6.1279 · Cited by 319
Diep, B. A., Carleton, H. A., Chang, R. F., Sensabaugh, G. F., & Perdreau‐Remington, F. (2006) · The Journal of Infectious Diseases · doi:10.1086/503777 · Cited by 310
Vancomycin: A 50-Year Reassessment
Moellering, R. C. (2006) · Clinical Infectious Diseases · doi:10.1086/491708 · Cited by 275
Sieradzki, K., & Tomasz, A. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.8.2557-2566.1997 · Cited by 274
Jones, M. E., Draghi, D. C., Thornsberry, C., Karlowsky, J. A., Sahm, D. F., & Wenzel, R. P. (2004) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-3-14 · Cited by 269
Gene Dosage and Linezolid Resistance in Enterococcus faecium and Enterococcus faecalis
Marshall, S. H., Donskey, C. J., Hutton-Thomas, R., Salata, R. A., & Rice, L. B. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.10.3334-3336.2002 · Cited by 263
Epidemiology of methicillin-resistant staphylococci in Europe
Stefani, S., & Varaldo, P. E. (2003) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2003.00698.x · Cited by 253
A Proteolytic Transmembrane Signaling Pathway and Resistance to β-Lactams in Staphylococci
Zhang, H. Z., Hackbarth, C. J., Chansky, K. M., & Chambers, H. F. (2001) · Science · doi:10.1126/science.1055144 · Cited by 252
Meka, V. G., Pillai, S. K., Sakoulas, G., Wennersten, C., Venkataraman, L., DeGirolami, P. C., Eliopoulos, G. M., Moellering, Jr., & Gold, H. S. (2004) · The Journal of Infectious Diseases · doi:10.1086/421471 · Cited by 247
Melzer, M., Eykyn, S. J., Gransden, W. R., & Chinn, S. (2003) · Clinical Infectious Diseases · doi:10.1086/379321 · Cited by 241
Cui, L., Iwamoto, A., Lian, J.-Q., Neoh, H.-M., Maruyama, T., Horikawa, Y., & Hiramatsu, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.428-438.2006 · Cited by 240
Weigel, L. M., Donlan, R. M., Shin, D. H., Jensen, B., Clark, N. C., McDougal, L. K., Zhu, W., Musser, K. A., Thompson, J., Kohlerschmidt, D., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00576-06 · Cited by 237
O'Flaherty, S., Coffey, A., Meaney, W., Fitzgerald, G. F., & Ross, R. P. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.20.7161-7164.2005 · Cited by 234
Jones, M. E., Karlowsky, J. A., Draghi, D. C., Thornsberry, C., Sahm, D. F., & Nathwani, D. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00154-7 · Cited by 227
Pinho, M. G., Filipe, S. R., de Lencastre, H., & Tomasz, A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.22.6525-6531.2001 · Cited by 225
Surveillance and epidemiology of MRSA bacteraemia in the UK
Johnson, A. P., Pearson, A., & Duckworth, G. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki266 · Cited by 224
EXTRACHROMOSOMAL NATURE OF DRUG RESISTANCE IN STAPHYLOCOCCUS AUREUS*
Novick, R. P., & Bouanchaud, D. (1971) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1971.tb30664.x · Cited by 222
Fifteen-Year Study of the Changing Epidemiology of Methicillin-Resistant Staphylococcus aureus
Crum, N. F., Lee, R. U., Thornton, S. A., Stine, O. C., Wallace, M. R., Barrozo, C., Keefer-Norris, A., Judd, S., & Russell, K. L. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.01.004 · Cited by 204
Marty, F. M., Yeh, W. W., Wennersten, C. B., Venkataraman, L., Albano, E., Alyea, E. P., Gold, H. S., Baden, L. R., & Pillai, S. K. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.2.595-597.2006 · Cited by 199
Meticillin-resistant Staphylococcus aureus
Boyce, J. M., Cookson, B., Christiansen, K., Hori, S., Vuopio-Varkila, J., Kocagöz, S., Öztop, A. Y., Vandenbroucke-Grauls, C. M., Harbarth, S., & Pittet, D. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70243-7 · Cited by 187
Sakoulas, G., Eliopoulos, G. M., Moellering, Jr., Novick, R. P., Venkataraman, L., Wennersten, C., DeGirolami, P. C., Schwaber, M. J., & Gold, H. S. (2003) · The Journal of Infectious Diseases · doi:10.1086/368128 · Cited by 187
Patel, J. B., Jevitt, L. A., Hageman, J., McDonald, L. C., & Tenover, F. C. (2006) · Clinical Infectious Diseases · doi:10.1086/504084 · Cited by 183
Howden, B. P., & Grayson, M. L. (2006) · Clinical Infectious Diseases · doi:10.1086/499365 · Cited by 182
Shore, A., Rossney, A. S., Keane, C. T., Enright, M. C., & Coleman, D. C. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.2070-2083.2005 · Cited by 170
Wu, S. W., de Lencastre, H., & Tomasz, A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.8.2417-2424.2001 · Cited by 167
ANTIMICROBIAL RESISTANCE IN STAPHYLOCOCCI
Maranan, M. C., Moreira, B., Boyle-Vavra, S., & Daum, R. S. (1997) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70392-5 · Cited by 166
Ruhe, J. J., Monson, T., Bradsher, R. W., & Menon, A. (2005) · Clinical Infectious Diseases · doi:10.1086/429628 · Cited by 166
Han, L. L., McDougal, L. K., Gorwitz, R. J., Mayer, K. H., Patel, J. B., Sennott, J. M., & Fontana, J. L. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02274-06 · Cited by 156
Reinventing phage therapy: are the parts greater than the sum?
Fischetti, V. A., Nelson, D. C., & Schuch, R. (2006) · Nature Biotechnology · doi:10.1038/nbt1206-1508 · Cited by 155
馬, 笑. (2004) · Medical Entomology and Zoology · Cited by 152
The Growing Menace of Community-Acquired Methicillin-Resistant Staphylococcus aureus
Moellering, R. C. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-5-200603070-00014 · Cited by 145
Schmitz, F., Jones, M. E., Hofmann, B., Hansen, B., Scheuring, S., Lückefahr, M., Fluit, A. C., Verhoef, J., Hadding, U., Heinz, H., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.5.1249 · Cited by 137
Combination Antibiotic Therapy for Infective Endocarditis
Le, T., & Bayer, A. S. (2003) · Clinical Infectious Diseases · doi:10.1086/367661 · Cited by 126
Patel, M., Waites, K. B., Moser, S. A., Cloud, G. A., & Hoesley, C. J. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.02582-05 · Cited by 119
Tsuji, B. T., Rybak, M. J., Lau, K. L., & Sakoulas, G. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00671-06 · Cited by 90
Sader, H. S., Fritsche, T. R., & Jones, R. N. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01491-05 · Cited by 86
Mechanisms of daptomycin resistance in Staphylococcus aureus
Kaatz, G. W., Lundstrom, T. S., & Seo, S. M. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.05.030 · Cited by 85
Vikram, H. R., Havill, N. L., Koeth, L. M., & Boyce, J. M. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.5384-5387.2005 · Cited by 71
Bobin-Dubreux, S., Reverdy, M. E., Nervi, C., Rougier, M., Bolmström, A., Vandenesch, F., & Étienne, J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.349-352.2001 · Cited by 70
West, T. E., Guerry, C., Hiott, M., Morrow, N., Ward, K. S., & Salgado, C. D. (2006) · Infection Control and Hospital Epidemiology · doi:10.1086/500372 · Cited by 65
Derivatives of a Vancomycin-ResistantStaphylococcus aureusStrain Isolated at Hershey Medical Center
Bozdoğan, B., Ednie, L. M., Credito, K. L., Kosowska, K., & Appelbaum, P. C. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4762-4765.2004 · Cited by 58
O'Sullivan, M. V. N., Cai, Y., Kong, F., Zeng, X., & Gilbert, G. L. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01632-06 · Cited by 51
Cassone, M., Campanile, F., Pantosti, A., Venditti, M., & Stefani, S. (2004) · Microbial Drug Resistance · doi:10.1089/107662904323047790 · Cited by 38
Self-citationRybak, M. J., Cha, R., Cheung, C. M., Meka, V. G., & Kaatz, G. W. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2004.09.005 · Cited by 22
Lindsay, J. A. (2007) · Future Microbiology · doi:10.2217/17460913.2.1.1 · Cited by 7
Cited by
Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus
Walker, M. J., Barnett, T. C., McArthur, J. D., Cole, J. N., Gillen, C. M., Henningham, A., Sriprakash, K. S., Sanderson-Smith, M. L., & Nizet, V. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00101-13 · Cited by 908
Mobile genetic elements of Staphylococcus aureus
Malachowa, N., & DeLeo, F. R. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0389-4 · Cited by 560
Basis of Virulence in Community-Associated Methicillin-Resistant Staphylococcus aureus
Otto, M. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134309 · Cited by 457
Neutrophils in innate host defense against Staphylococcus aureus infections
Rigby, K. M., & DeLeo, F. R. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0295-3 · Cited by 400
Resistance of Gram-Positive Bacteria to Current Antibacterial Agents and Overcoming Approaches
Jubeh, B., Breijyeh, Z., & Karaman, R. (2020) · Molecules · doi:10.3390/molecules25122888 · Cited by 383
Metadata
- Authors
- Pantosti, A., Sanchini, A., & Monaco, M.
- Venue
- Future Microbiology
- Publisher
- Informa UK Limited
- Published
- 2007-05-24
- Volume
- 2
- Issue
- 3
- Pages
- 323-334
- ISSN
- 1746-0913 (ISSN-L)
- 1746-0921
- OpenAlex
- W2140112763
- Cited by
- 348
- References
- 84
- FWCI
- 3.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.